Cochrane · systematic review · CD000433

Protein supplementation of human milk for promoting growth in preterm infants

Amissah, EA, Brown, J, Harding, JE · Cochrane Database of Systematic Reviews · 2020 · Cochrane Library

Neonatal2 versionsAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
7
current version
GRADE rated
6
No studies
1
Included studies
NR
No studies 1 · 14.3%Ungraded 0 · 0%Very low 3 · 42.9%Low 3 · 42.9%Moderate 0 · 0%High 0 · 0%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Questions and results

Show all 2 versions

Protein supplementation compared to control for promoting growth in preterm infants

Population: preterm infants
7 questions
OutcomeEffectEvidenceStatus / GRADE
Growth: weight (weight gain g/kg/day)
Protein supplementation vs control
no estimate extracted5 studies · 101 participantsLow
Downgraded: risk of bias
Growth: length (cm/week)
Protein supplementation vs control
no estimate extracted4 studies · 68 participantsLow
Downgraded: risk of bias
Growth: head circumference (cm/week)
Protein supplementation vs control
no estimate extracted4 studies · 68 participantsLow
Downgraded: risk of bias
Neurodevelopmental outcomes
Protein supplementation vs control
no estimate extractedNRNo studies
Duration of hospital stay (days)
Protein supplementation vs control
no estimate extracted1 study · 20 participantsVery low
Downgraded: risk of bias
Feeding intolerance
Protein supplementation vs control
RR 2.7 [0.13, 58.24]1 study · 17 participantsVery low
Downgraded: risk of bias
Necrotising enterocolitis
Protein supplementation vs control
RR 1.11 [0.07, 18.49]1 study · 76 participantsVery low
Downgraded: risk of bias